Post by
subaru1i on Sep 20, 2023 8:31am
What are future profits for LABS? The research report
indicated cannabinoid pharmaceutical API's will be worth $25 billion by 2025. Let's say LABS only gets $10 billion of that pie so what does that do to LABS stock price when you have over $2 Billion in PROFITS? Without having to go into the math while my mind is pondering that second cup of coffee, it is over $50 per share. Enjoy the profit margin below and we are in VERY GOOD shape!!! A forward looking P/E ratio in a new disruptive and fast growing segment of 25 is not unreasonable during the hyper growth phase of a company.
MediPharm has made significant improvement in its adjusted gross margin. In the last reported quarter, Q2 2023, this was approximately 21%
Comment by
Hoover69 on Sep 20, 2023 9:10am
I am long but these numbers are crazy! Only $10 billion of the $25 billion - that is a 40% share - very unlikely. Going from .08 to $50 - not in your lifetime. This would result in a market cap of $20 billion making it the 35th largest company in Canada! You lose most folks with this level of ridiculous pumping. IMO. GLTA.